Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Avogaro

Showing results (171-180 of 426) with videos related to

Pageof 43
Sort By:
Acta Diabetologica|May 25, 2012
Elevated white blood cell count is associated with prevalence and development of the metabolic syndrome and its components in the general populationGian Paolo Fadini, Giorgio Marcuzzo, Maria Cristina Marescotti, et al.
Diabetes/Metabolism Research and Reviews|April 25, 2025
Long-Term Effectiveness of Once-Weekly Semaglutide in Patients With Type 2 Diabetes Previously Treated With Insulin. A Multicentre Real-World StudyBenedetta Maria Bonora, Andrea Giaccari, Agostino Consoli, et al.
Aging Clinical and Experimental Research|March 3, 2005
The effects of oral amino acid intake on ambulatory capacity in elderly subjectsRoldano Scognamiglio, Angelo Avogaro, Christian Negut, et al.
European Journal of Preventive Cardiology|April 1, 2011
Prediabetes influences cardiac rehabilitation in coronary artery disease patientsNicola Russo, Leonida Compostella, Gianpaolo Fadini, et al.
Cardiovascular Diabetology|June 12, 2020
Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practiceEnrico Longato, Barbara Di Camillo, Giovanni Sparacino, et al.
Clinical Cardiology|March 11, 2005
Abnormal myocardial perfusion and contractile recruitment during exercise in type 1 diabetic patientsRoldano Scognamiglio, Christian Negut, Saula Vigili de Kreuizenberg, et al.
IEEE Journal of Biomedical and Health Informatics|March 12, 2021
A Deep Learning Approach to Predict Diabetes' Cardiovascular Complications From Administrative ClaimsEnrico Longato, Gian Paolo Fadini, Giovanni Sparacino, et al.
European Journal of Preventive Cardiology|February 24, 2021
Cardiovascular effectiveness of human-based vs. exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetesEnrico Longato, Barbara Di Camillo, Giovanni Sparacino, et al.
Cardiovascular Diabetology|November 14, 2021
Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective studyEnrico Longato, Barbara Di Camillo, Giovanni Sparacino, et al.
Diabetes/Metabolism Research and Reviews|May 27, 2020
Comparative effectiveness of dapagliflozin vs DPP-4 inhibitors on a composite endpoint of HbA1c, body weight and blood pressure reduction in the real worldMario Luca Morieri, Agostino Consoli, Giorgio Sesti, et al.
Pageof 43

Showing results (171-180 of 426) with videos related to

Sort By:
Pageof 43
Acta Diabetologica|May 25, 2012
Elevated white blood cell count is associated with prevalence and development of the metabolic syndrome and its components in the general populationGian Paolo Fadini, Giorgio Marcuzzo, Maria Cristina Marescotti, et al.
Diabetes/Metabolism Research and Reviews|April 25, 2025
Long-Term Effectiveness of Once-Weekly Semaglutide in Patients With Type 2 Diabetes Previously Treated With Insulin. A Multicentre Real-World StudyBenedetta Maria Bonora, Andrea Giaccari, Agostino Consoli, et al.
Aging Clinical and Experimental Research|March 3, 2005
The effects of oral amino acid intake on ambulatory capacity in elderly subjectsRoldano Scognamiglio, Angelo Avogaro, Christian Negut, et al.
European Journal of Preventive Cardiology|April 1, 2011
Prediabetes influences cardiac rehabilitation in coronary artery disease patientsNicola Russo, Leonida Compostella, Gianpaolo Fadini, et al.
Cardiovascular Diabetology|June 12, 2020
Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practiceEnrico Longato, Barbara Di Camillo, Giovanni Sparacino, et al.
Clinical Cardiology|March 11, 2005
Abnormal myocardial perfusion and contractile recruitment during exercise in type 1 diabetic patientsRoldano Scognamiglio, Christian Negut, Saula Vigili de Kreuizenberg, et al.
IEEE Journal of Biomedical and Health Informatics|March 12, 2021
A Deep Learning Approach to Predict Diabetes' Cardiovascular Complications From Administrative ClaimsEnrico Longato, Gian Paolo Fadini, Giovanni Sparacino, et al.
European Journal of Preventive Cardiology|February 24, 2021
Cardiovascular effectiveness of human-based vs. exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetesEnrico Longato, Barbara Di Camillo, Giovanni Sparacino, et al.
Cardiovascular Diabetology|November 14, 2021
Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective studyEnrico Longato, Barbara Di Camillo, Giovanni Sparacino, et al.
Diabetes/Metabolism Research and Reviews|May 27, 2020
Comparative effectiveness of dapagliflozin vs DPP-4 inhibitors on a composite endpoint of HbA1c, body weight and blood pressure reduction in the real worldMario Luca Morieri, Agostino Consoli, Giorgio Sesti, et al.
Pageof 43